Physician profile
Amanda Webb
NPI 1275763690
$3,343.60
in general payments reported to CMS, 2019-2025
34 companies · $788 in 2025
The $788 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $663 · 2023: $1,252 · 2024: $483 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,522.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $981.19 | 2022-2025 | |
| Novo Nordisk INC | $279.90 | 2021-2023 | Wegovy, Rybelsus, Ozempic |
| Viiv Healthcare Company | $203.42 | 2022-2024 | Apretude |
| Lilly USA, LLC | $198.84 | 2022-2024 | Mounjaro, Taltz, Zepbound |
| Regeneron Healthcare Solutions, INC. | $190.97 | 2024-2025 | Dupixent, Libtayo |
| Pfizer INC. | $141.48 | 2023 | |
| Amgen INC. | $139.78 | 2022-2024 | Otezla, Repatha |
| Gilead Sciences, INC. | $122.86 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $118.71 | 2022-2023 | Farxiga, Breztri, Airsupra |
| Galderma Laboratories, L.P. | $104.96 | 2025 | Dysport |
| Astellas Pharma US INC | $90.49 | 2022-2023 | Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $80.07 | 2022-2023 | |
| Corium, LLC | $74.61 | 2022-2023 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $66.90 | 2022 | |
| Horizon Therapeutics Plc | $51.21 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $45.11 | 2022-2024 | Thinprep 2000 Processor, Aptima |
| Incyte Corporation | $37.21 | 2024-2025 | Opzelura |
| Esperion Therapeutics, INC. | $35.73 | 2022-2023 | Nexletol |
| Glaxosmithkline, LLC. | $34.56 | 2022-2023 | Shingrix, Arexvy |
| Idorsia Pharmaceuticals US INC | $34.54 | 2022-2023 | Quviviq |
| Genzyme Corporation | $33.77 | 2025 | |
| Sanofi-Aventis U.S. LLC | $31.83 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.57 | 2021 | |
| Merck Sharp & Dohme LLC | $26.76 | 2023 | Vaxneuvance, Gardasil 9, Pneumovax 23 |
| Sanofi Pasteur INC. | $25.18 | 2023 | |
| Novartis Pharmaceuticals Corporation | $22.23 | 2023 | |
| Exact Sciences Corporation | $21.90 | 2023 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $19.62 | 2022 | |
| Allergan, INC. | $18.52 | 2022 | |
| Exeltis, USA INC. | $18.02 | 2023 | Slynd |
| Biofrontera INC. | $17.02 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
| Ucb, INC. | $16.96 | 2025 | Bimzelx |
| Lucid Diagnostics INC. | $15.79 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.89 | 2023 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.